Stock

What the S&P 500, VIX, and ARKK are Telling Us Now

Read more
Stock

Three Sectors Stand Out and One Sports a Bullish Breakout

Read more
Stock

Is a Bold Rotation Brewing in Healthcare and Biotech? Here’s What to Watch Now

Read more
Stock

Bearish Divergence Suggests Caution For S&P 500

Read more
Investing

Harvest Gold Announces Annual General Meeting Results

Read more
Investing

Editor’s Picks: Trump to Lift Minnesota Mining Ban, Dundee Buys Adriatic, China Tightens Rare Earth Grip

Read more
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Victoria Gold-Silver Exploration Update

June 5, 2025

Appeals Court Grants Trump Temporary Reprieve on Tariffs,...

May 31, 2025

Variation to Noteholder Agreements

May 22, 2025

Finlay Minerals Announces Closing of Non-Brokered Private Placement...

June 10, 2025

China Eases Rare Earths Grip, Grants US, EU...

June 10, 2025

WCN Raises A$14.4M at an Average 29% Premium...

May 19, 2025

CDX May Investor Presentation

May 30, 2025

Coelacanth Announces Q1 2025 Financial and Operating Results

May 29, 2025

Feedback of U.S. Department of Defense Award Funding

May 19, 2025

Crypto Market Recap: Stablecoin Market Makes Headway, SharpLink...

June 14, 2025